Skip to main content

Jaume Mestre Torres

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Jaume Mestre Torres

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

Manuel Requena Ruiz

Manuel Requena Ruiz

Senior researcher
Stroke research
Read more
Miriam Martos Fernández

Miriam Martos Fernández

New Technologies and Craniofacial Microsurgery
Read more
Cristina  Esperidón Navarro

Cristina Esperidón Navarro

Research technician
Research Group of Physical Medicine and Rehabilitation
Read more
Javier Garcia Fernandez

Javier Garcia Fernandez

Main researcher
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.